The estimated Net Worth of Kari Leigh Keese is at least $3.22 millió dollars as of 31 January 2024. Kari Keese owns over 6,167 units of Axonics Inc stock worth over $3,217,389 and over the last few years Kari sold AXNX stock worth over $0.
Kari has made over 1 trades of the Axonics Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Kari exercised 6,167 units of AXNX stock worth $423,858 on 31 January 2024.
The largest trade Kari's ever made was exercising 6,167 units of Axonics Inc stock on 31 January 2024 worth over $423,858. On average, Kari trades about 6,167 units every 0 days since 2024. As of 31 January 2024 Kari still owns at least 46,812 units of Axonics Inc stock.
You can see the complete history of Kari Keese stock trades at the bottom of the page.
Kari's mailing address filed with the SEC is 26, Technology Drive, Irvine Spectrum, Irvine, Orange County, California, 92618, United States.
Over the last 6 years, insiders at Axonics Inc have traded over $108,010,643 worth of Axonics Inc stock and bought 4,672,163 units worth $70,180,620 . The most active insiders traders include Asset Management, Lp Chen B..., Shahzad Malik és Geoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of $4,280,711. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth $2,383,374.
axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.
Axonics Inc executives and other stock owners filed with the SEC include: